The top read ophthalmology articles of 2025 focused on a variety of topics within the field, including links between ...

In the EPCORE DLBCL-3 study, fixed-duration epcoritamab monotherapy delivered deep, durable responses with manageable ...

OneOncology supports 33 practices, providing infrastructure and expertise for advanced therapies and value-based care, while ...

A reimbursable, team-based remote blood pressure monitoring program significantly improved hypertension control in patients ...

AA is a chronic, immune-mediated dermatologic condition characterized by non-scarring hair loss, affecting approximately 1% to 2% of the global population. Its unpredictable course and visible ...

As therapy for chronic lymphocytic leukemia (CLL) continues to evolve, 2025 brought research, regulatory news, and expert ...

Here are the most-read “5 things” articles from 2025.

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels ...

High risk of obstructive sleep apnea (OSA) is linked to a 40% increase in poor mental health outcomes, including depression ...

The 30th European Hematology Association (EHA) Congress (EHA 2025), held in Milan, Italy, from June 12-15, 2025, continued ...

Covalent Bruton tyrosine kinase inhibitors (BTKis) have improved CLL management, but discontinuation due to adverse events ...

The top 5 most-viewed videos of 2025 explored a range of topics, including data presented at major medical meetings, health ...